For research use only. Not for therapeutic Use.
Nor Neostigmine-d6 is a deuterated form of nor neostigmine, a metabolite of neostigmine, which is used to treat myasthenia gravis and reverse the effects of muscle relaxants. In this version, six hydrogen atoms are replaced with deuterium, enhancing its utility in pharmacokinetic and metabolic studies. The deuterium labeling allows for precise tracking and differentiation in mass spectrometry and NMR spectroscopy, facilitating detailed research into the drug’s absorption, distribution, metabolism, and excretion. Despite the isotopic modification, it retains the same biological activity, making it valuable for research purposes.
| Catalog Number | R058665 |
| CAS Number | NA |
| Synonyms | Dimethylcarbamic Acid 3-(Dimethylamino-d6)phenyl Ester; Dimethylcarbamic Acid m-(Dimethylamino-d6)phenyl Ester; 3-(Dimethylamino-d6)phenyl Dimethylcarbamate; Norneostigmine-d6; |
| Molecular Formula | C₁₁H₁₀D₆N₂O₂ |
| Purity | ≥95% |
| Storage | -20°C |
